SE9703226D0 - New pharmaceutical composition - Google Patents

New pharmaceutical composition

Info

Publication number
SE9703226D0
SE9703226D0 SE9703226A SE9703226A SE9703226D0 SE 9703226 D0 SE9703226 D0 SE 9703226D0 SE 9703226 A SE9703226 A SE 9703226A SE 9703226 A SE9703226 A SE 9703226A SE 9703226 D0 SE9703226 D0 SE 9703226D0
Authority
SE
Sweden
Prior art keywords
composition
pharmaceutical composition
physiologically acceptable
new pharmaceutical
parts
Prior art date
Application number
SE9703226A
Other languages
English (en)
Swedish (sv)
Inventor
Stefan Friess
Harald Heckenmueller
Heike Kublik
Oliver Szambien
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9703226A priority Critical patent/SE9703226D0/xx
Publication of SE9703226D0 publication Critical patent/SE9703226D0/xx
Priority to PCT/SE1998/001568 priority patent/WO1999012521A1/fr
Priority to CA002302710A priority patent/CA2302710A1/fr
Priority to US09/155,250 priority patent/US6258374B1/en
Priority to JP2000510420A priority patent/JP2001515851A/ja
Priority to EP98943141A priority patent/EP1011636A1/fr
Priority to AU90999/98A priority patent/AU731208B2/en
Priority to IS5393A priority patent/IS5393A/is
Priority to NO20001160A priority patent/NO20001160L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9703226A 1997-09-08 1997-09-08 New pharmaceutical composition SE9703226D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9703226A SE9703226D0 (sv) 1997-09-08 1997-09-08 New pharmaceutical composition
PCT/SE1998/001568 WO1999012521A1 (fr) 1997-09-08 1998-09-03 Composition pharmaceutique moussante
CA002302710A CA2302710A1 (fr) 1997-09-08 1998-09-03 Composition pharmaceutique moussante
US09/155,250 US6258374B1 (en) 1997-09-08 1998-09-03 Foam-forming pharmaceutical composition
JP2000510420A JP2001515851A (ja) 1997-09-08 1998-09-03 新たなフォーム形成性医薬組成物
EP98943141A EP1011636A1 (fr) 1997-09-08 1998-09-03 Composition pharmaceutique moussante
AU90999/98A AU731208B2 (en) 1997-09-08 1998-09-03 New foam-forming pharmaceutical composition
IS5393A IS5393A (is) 1997-09-08 2000-03-02 Ný froðumyndandi lyfjablanda
NO20001160A NO20001160L (no) 1997-09-08 2000-03-07 Nytt skumdannende farmasøytisk preparat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703226A SE9703226D0 (sv) 1997-09-08 1997-09-08 New pharmaceutical composition

Publications (1)

Publication Number Publication Date
SE9703226D0 true SE9703226D0 (sv) 1997-09-08

Family

ID=20408171

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9703226A SE9703226D0 (sv) 1997-09-08 1997-09-08 New pharmaceutical composition

Country Status (9)

Country Link
US (1) US6258374B1 (fr)
EP (1) EP1011636A1 (fr)
JP (1) JP2001515851A (fr)
AU (1) AU731208B2 (fr)
CA (1) CA2302710A1 (fr)
IS (1) IS5393A (fr)
NO (1) NO20001160L (fr)
SE (1) SE9703226D0 (fr)
WO (1) WO1999012521A1 (fr)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5503973A (en) * 1992-05-29 1996-04-02 The Regents Of The University Of California Method for inhibition of viral morphogenesis
US20030181355A1 (en) * 1992-05-29 2003-09-25 Glenn Jeffrey S. Method for inhibition of viral infection
US7078391B2 (en) * 1997-02-10 2006-07-18 Inspire Pharmaceuticals, Inc. Method of treating edematous retinal disorders
US6818629B2 (en) * 1997-02-10 2004-11-16 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
US7223744B2 (en) * 1997-02-10 2007-05-29 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
US6872710B2 (en) * 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
WO2004028444A2 (fr) * 1999-06-02 2004-04-08 Scantibodies Laboratory, Inc. Antagonistes de la parathormone et utilisations de ceux-ci
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
AUPQ105799A0 (en) 1999-06-18 1999-07-08 Victor Chang Cardiac Research Institute, The Cell growth inhibition
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US6852323B2 (en) 2000-07-21 2005-02-08 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US6867199B2 (en) * 2000-08-21 2005-03-15 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapeutic use
ES2286285T3 (es) * 2001-09-04 2007-12-01 Dow Global Technologies Inc. Procedimiento para dispensar un fluido en particulas solidas.
CN1251763C (zh) * 2001-09-04 2006-04-19 陶氏环球技术公司 含水空气泡沫
CN1203055C (zh) 2001-09-26 2005-05-25 朱德煦 治疗或预防细菌感染的方法和组合物
US7939497B2 (en) * 2002-03-08 2011-05-10 Shanghai Institutes For Biological Sciences, Cas Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof
CA2480099C (fr) * 2002-03-26 2019-01-08 Zensun (Shanghai) Sci-Tech. Ltd. Procedes fondes sur l'utilisation de erbb3 et compositions associees de traitement des neoplasmes
AU2002304965A1 (en) 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7517887B2 (en) * 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
US7196093B2 (en) * 2003-04-09 2007-03-27 General Atomics Reversible inhibitors of SAH hydrolase and uses thereof
US7868011B2 (en) * 2003-04-09 2011-01-11 General Atomics Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
WO2005027851A2 (fr) * 2003-09-18 2005-03-31 Children's Medical Center Corporation Traitement de la colite distale aiguë
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
EP1699431B1 (fr) * 2003-12-12 2015-08-19 Otic Pharma Ltd. Compositions pour le traitement de troubles auriculaires et procedes d'utilisation de ces compositions
US20050186271A1 (en) * 2004-02-24 2005-08-25 Sheskey Paul J. Process for dispersing a fluid in a mass of solid particles
US8211449B2 (en) * 2004-06-24 2012-07-03 Dpt Laboratories, Ltd. Pharmaceutically elegant, topical anhydrous aerosol foam
US20060147504A1 (en) * 2004-12-30 2006-07-06 Bobby Corry Feminine anti-itch cloth
US8252308B2 (en) * 2005-01-27 2012-08-28 C.B. Fleet Company Inc. Feminine anti-itch gel
BRPI0612448A2 (pt) 2005-05-09 2010-11-23 Foamix Ltd composição espumosa de sacarìdeo
CN1869002A (zh) * 2005-05-27 2006-11-29 中国科学院上海药物研究所 一类非甾体雄激素受体调节剂、其制备方法和用途
WO2007082698A1 (fr) * 2006-01-19 2007-07-26 Disphar International B.V. Composition moussante
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2008106646A2 (fr) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Procédés et formulations pour une thérapie génique topique
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (fr) 2007-11-30 2009-06-04 Foamix Ltd. Peroxyde de benzoyle contenant de la mousse
WO2009072007A2 (fr) 2007-12-07 2009-06-11 Foamix Ltd. Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
WO2010041141A2 (fr) 2008-10-07 2010-04-15 Foamix Ltd. Support expansible à base d’huile et préparations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses légères, et leurs utilisations
CA2769677A1 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes a base d'agents non tensioactifs non polymeres, mousses legeres, et leurs utilisations
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US7888062B1 (en) 2010-02-01 2011-02-15 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
US8445226B2 (en) * 2010-02-01 2013-05-21 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
US12661407B2 (en) 2010-04-08 2026-06-23 Journey Medical Corporation Compositions, gels and foams with rheology modulators and uses thereof
AU2010355614B2 (en) 2010-06-13 2015-07-02 Institute Of Biophysics, Chinese Academy Of Sciences Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof
WO2013053076A1 (fr) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions et procédés pour le traitement de l'insuffisance cardiaque
CA2886396C (fr) 2012-07-23 2023-08-22 Institute Of Biophysics, Chinese Academy Of Sciences Methode d'induction de la differenciation de cellules souches pluripotentes en myocytes ventriculaires in vitro
RU2650635C2 (ru) 2012-10-08 2018-04-16 Цзэньсунь (Шанхай) Сайенс Энд Текнолоджи, Ко., Лтд. Композиции и способы лечения сердечной недостаточности у пациентов с диабетом
CA2911848A1 (fr) 2013-05-22 2014-11-27 Zensun (Shanghai) Science & Technology, Ltd. Liberation prolongee de neureguline pour le traitement de l'insuffisance cardiaque
CA2920835A1 (fr) 2013-08-20 2015-02-26 Anutra Medical, Inc. Systeme de remplissage de seringue et procede associe
USD774182S1 (en) 2014-06-06 2016-12-13 Anutra Medical, Inc. Anesthetic delivery device
USD750768S1 (en) 2014-06-06 2016-03-01 Anutra Medical, Inc. Fluid administration syringe
USD763433S1 (en) 2014-06-06 2016-08-09 Anutra Medical, Inc. Delivery system cassette
US20190100725A1 (en) 2016-03-18 2019-04-04 Institute Of Biophysics, Chinese Academy Of Sciences Cell culture medium and culture medium supplement
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
CN113289002A (zh) 2020-02-24 2021-08-24 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延缓心力衰竭的方法和组合物
US11447687B2 (en) 2020-09-29 2022-09-20 Saudi Arabian Oil Company Enhancing rheological properties of foam using aloe-barbadensis gel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613497A (en) 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
US4599082A (en) * 1984-08-13 1986-07-08 Becton, Dickinson And Company Two-component syringe assembly
DE3674483D1 (de) * 1985-06-27 1990-10-31 Duphar Int Res Mehrkammerspritze.
US4613326A (en) * 1985-07-12 1986-09-23 Becton, Dickinson And Company Two-component medication syringe assembly
US4929230A (en) * 1988-09-30 1990-05-29 Pfleger Frederick W Syringe construction
US5089606A (en) 1989-01-24 1992-02-18 Minnesota Mining And Manufacturing Company Water-insoluble polysaccharide hydrogel foam for medical applications

Also Published As

Publication number Publication date
AU731208B2 (en) 2001-03-29
EP1011636A1 (fr) 2000-06-28
NO20001160D0 (no) 2000-03-07
AU9099998A (en) 1999-03-29
NO20001160L (no) 2000-05-08
JP2001515851A (ja) 2001-09-25
US6258374B1 (en) 2001-07-10
IS5393A (is) 2000-03-02
WO1999012521A1 (fr) 1999-03-18
CA2302710A1 (fr) 1999-03-18

Similar Documents

Publication Publication Date Title
CY1105816T1 (el) Χρηση θepαπειας με νευροτοξινη για την αντιμετωπιση της κατακρατησης ουρων
DK0969813T3 (da) Topisk farmaceutisk sammensætning omfattende et kolinergt middel eller et calciumkanalblokerende middel
BR9810089A (pt) Processo para tratar uma fêmea humana sofrendo de dismenorréia, composição farmaceuticamente aceitável, e, dispositivo para suprir um agente farmacêutico a um útero de fêmea
ATE241361T1 (de) Mittel zur hormonalen kontrazeption
NO20001567D0 (no) Bioadhesive sammensetninger og fremgangsmåter for topisk administrering av aktive midler
BR9508788A (pt) Composição farmacêutica artigo para fornecer uma composição farmacêutica uso da composição processo de tratamento das condições do cólon ou do trato gastro-intestinal inferior do corpo humano ou animal e de combate de doenças transmitidas sexualmente e composição de formação de espuma aguosa
CO5680109A1 (es) Compuestos para el tratamiento de la disfuncion sexual femenina
ATE191468T1 (de) Metalloproteinase inhibitoren
IS6209A (is) Ný blanda
BR0109378A (pt) Pelìculas oralmente consumìveis de rápida dissolução contendo uma resina de permuta de ìon como um agente de mascaramento de sabor
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
AR032352A1 (es) Composicion farmaceutica bioadhesiva de hidratacion gradual y su uso en la fabricacion de un medicamento para la administracion de testosterona y terbutalina a un mamifero a traves de una superficie de mucosa.
SE9704833D0 (sv) New formulation
MX9702162A (es) Procedimiento para hacer unidades de dosis mediante granulacion en humedo.
ATE432066T1 (de) Arzneimittel für die dickdarmverabreichung von wirkstoffen
UA90077C2 (uk) Антидисритмічні агенти для лікування тазового болю, що призначаються вагінально
NO964155L (no) Progesteronantagonister for fremstilling av legemidler til behandling av dysfunksjonelle uterusblödninger
BR9901782A (pt) Forma para dosagem de nefazodona.
ATE320796T1 (de) Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz
ATE291914T1 (de) Zolmitriptanhaltige arzneizusammensetzungen
ES2185897T3 (es) Uso de 2-carnitinas de alcanoilo para la fabricacion de un medicamento para el tratamiento de enfermedades inflamatorias del intestino.
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
SE0001916D0 (sv) Novel formulation
AU9028098A (en) Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception